| 1 |
Argenteri A, de Donato G, Setacci F, et al. History of the diagnosis and treatment of critical limb ischemia and diabetic foot[J]. Semin Vasc Surg, 2018, 31(2-4):25-42.
|
| 2 |
Soria-Juan B, Escacena N, Capilla-González V, et al. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 Diabetes Mellitus[J]. Front Immunol, 2019, 10:1151. doi: 10.3389/fimmu.2019.01151. |
| 3 |
Brown C, McKee C, Bakshi S, et al. Mesenchymal stem cells: Cell therapy and regeneration potential[J]. J Tissue Eng Regen Med, 2019, 13(9):1738-1755.
|
| 4 |
Gnecchi M, Melo LG. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium[J]. Methods Mol Biol, 2009, 482:281-294.
|
| 5 |
Pereira AR, Mendes TF, Ministro A, et al. Therapeutic angiogenesis induced by human umbilical cord tissue-derived mesenchymal stromal cells in a murine model of hindlimb ischemia[J]. Stem Cell Res Ther, 2016, 7(1):145.
|
| 6 |
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells[J]. Mol Biol Cell, 2002, 13(12):4279-4295.
|
| 7 |
Karaöz E, Demircan PC, Sağlam O, et al. Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells[J]. Histochem Cell Biol, 2011, 136(4):455-473.
|
| 8 |
Orciani M, Di Primio R. Skin-derived mesenchymal stem cells: isolation, culture, and characterization[J]. Methods Mol Biol, 2013, 989:275-283.
|
| 9 |
Robb KP, Fitzgerald JC, Barry F, et al. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency[J]. Cytotherapy, 2019, 21(3):289-306.
|
| 10 |
Ferreira JR, Teixeira GQ, Santos SG, et al. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning[J]. Front Immunol, 2018, 9:2837. doi: 10.3389/fimmu.2018.02837. |
| 11 |
Regmi S, Pathak S, Kim JO, et al. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives[J]. Eur J Cell Biol, 2019, 98(5-8):151041.
|
| 12 |
Uder C, Brückner S, Winkler S, et al. Mammalian MSC from selected species: Features and applications[J]. Cytometry A, 2018, 93(1):32-49.
|
| 13 |
Konala VBR, Bhonde R, Pal R. Secretome studies of mesenchymal stromal cells (MSCs) isolated from three tissue sources reveal subtle differences in potency[J]. In Vitro Cell Dev Biol Anim, 2020, 56(9):689-700.
|
| 14 |
Yu M, Liu W, Li J, et al. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway[J]. Stem Cell Res Ther, 2020, 11(1):350.
|
| 15 |
Samakova A, Gazova A, Sabova N, et al. The PI3k/Akt pathway is associated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia[J]. Physiol Res, 2019, 68(Suppl 2):S131-s138.
|
| 16 |
Zhao W, Zhang S, Wang B, et al. Runx2 and microRNA regulation in bone and cartilage diseases[J]. Ann N Y Acad Sci, 2016, 1383(1):80-87.
|
| 17 |
Park JS, Chu JS, Tsou AD, et al. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β[J]. Biomaterials, 2011, 32(16):3921-3930.
|
| 18 |
Chinnadurai R, Copland IB, Patel SR, et al. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells[J]. J Immunol, 2014, 192(4):1491-1501.
|
| 19 |
Spaggiari GM, Abdelrazik H, Becchetti F, et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2[J]. Blood, 2009, 113(26):6576-6583.
|
| 20 |
Zhang Q, Fu L, Liang Y, et al. Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation[J]. J Cell Physiol, 2018, 233(9):6832-6840.
|
| 21 |
Gao WH, Gao HY, Li YT, et al. Effectiveness of umbilical cord mesenchymal stem cells in patients with critical limb ischemia[J]. Med Clin (Barc), 2019, 153(9):341-346.
|
| 22 |
Yang SS, Kim NR, Park KB, et al. A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease[J]. Int J Stem Cells, 2013, 6(1):37-44.
|
| 23 |
Chen S, Zhang W, Wang JM, et al. Differentiation of isolated human umbilical cord mesenchymal stem cells into neural stem cells[J]. Int J Ophthalmol, 2016, 9(1):41-47.
|
| 24 |
Pinheiro CH, de Queiroz JC, Guimarães-Ferreira L, et al. Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle[J]. Stem Cell Rev Rep, 2012, 8(2):363-374.
|
| 25 |
Glenn JD, Whartenby KA. Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy[J]. World J Stem Cells, 2014, 6(5):526-539.
|
| 26 |
Chatterjee D, Marquardt N, Tufa DM, et al. Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity[J]. Cell Commun Signal, 2014, 12:63.
|
| 27 |
Lu D, Jiang Y, Deng W, et al. Long-term outcomes of BMMSC compared with BMMNC for treatment of critical limb ischemia and foot ulcer in patients with diabetes[J]. Cell Transplant, 2019, 28(5):645-652.
|
| 28 |
Bura A, Planat-Benard V, Bourin P, et al. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia[J]. Cytotherapy, 2014, 16(2):245-257.
|
| 29 |
Tabatabaei Qomi R, Sheykhhasan M. Adipose-derived stromal cell in regenerative medicine: A review[J]. World J Stem Cells, 2017, 9(8):107-117.
|
| 30 |
Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing[J]. Wound Repair Regen, 2014, 22(3):313-325.
|
| 31 |
Zollino I, Zuolo M, Gianesini S, et al. Autologous adipose-derived stem cells: Basic science, technique, and rationale for application in ulcer and wound healing[J]. Phlebology, 2017, 32(3):160-171.
|
| 32 |
De Gregorio C, Contador D, Díaz D, et al. Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice[J]. Stem Cell Res Ther, 2020, 11(1):168.
|
| 33 |
Nammian P, Asadi-Yousefabad SL, Daneshi S, et al. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy[J]. Stem Cell Res Ther, 2021, 12(1):58.
|
| 34 |
Gu YQ, Zhang J, Guo LR, et al. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia[J]. Chin Med J (Engl), 2008, 121(11):963-967.
|
| 35 |
Yan J, Liang J, Cao Y, et al. Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds[J]. Stem Cell Res Ther, 2021, 12(1):220.
|
| 36 |
Das AK, Bin Abdullah BJ, Dhillon SS, et al. Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study[J]. World J Surg, 2013, 37(4):915-922.
|
| 37 |
Shi R, Lian W, Jin Y, et al. Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats[J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(6):620-630.
|
| 38 |
An T, Chen Y, Tu Y, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Treatment of Diabetic Foot Ulcers: Application and Challenges[J]. Stem Cell Rev Rep, 2021, 17(2):369-378.
|
| 39 |
Casado-Díaz A, Quesada-Gómez JM, Dorado G. Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing[J]. Front Bioeng Biotechnol, 2020, 8:146.
|
| 40 |
Bailey AJM, Li H, Kirkham AM, et al. MSC-derived extracellular vesicles to heal diabetic wounds: a systematic review and meta-analysis of preclinical animal studies[J]. Stem Cell Rev Rep, 2021, 1-12. doi: 10.1007/s12015-021-10164-4. Online ahead of print. |
| 41 |
Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19[J]. Cardiovasc Res, 2020, 116(2):353-367.
|
| 42 |
Lasala GP, Silva JA, Minguell JJ. Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product[J]. J Thorac Cardiovasc Surg, 2012, 144(2):377-382.
|
| 43 |
Tebebi PA, Kim SJ, Williams RA, et al. Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound[J]. Sci Rep, 2017, 7:41550. doi: 10.1038/srep41550. |
| 44 |
Lee JH, Ryu JM, Han YS, et al. Fucoidan improves bioactivity and vasculogenic potential of mesenchymal stem cells in murine hind limb ischemia associated with chronic kidney disease[J]. J Mol Cell Cardiol, 2016, 97:169-179.
|
| 45 |
Kang WC, Oh PC, Lee K, et al. Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model[J]. Korean J Physiol Pharmacol, 2016, 20(6):657-667.
|
| 46 |
Pawitan JA, Bui TA, Mubarok W, et al. Enhancement of the Therapeutic Capacity of Mesenchymal Stem Cells by Genetic Modification: A Systematic Review[J]. Front Cell Dev Biol, 2020, 8:587776. doi: 10.3389/fcell.2020.587776. |
| 47 |
Choi B, Kim D, Han I, et al. Microenvironmental regulation of stem cell behavior through biochemical and biophysical stimulation[J]. Adv Exp Med Biol, 2018, 1064:147-160.
|
| 48 |
Chen C, Bai X, Ding Y, et al. Electrical stimulation as a novel tool for regulating cell behavior in tissue engineering[J]. Biomater Res, 2019, 23:25.
|
| 49 |
De Becker A, Riet IV. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?[J]. World J Stem Cells, 2016, 8(3):73-87.
|
| 50 |
Schira J, Falkenberg H, Hendricks M, et al. Characterization of regenerative phenotype of unrestricted somatic stem cells (USSC) from human umbilical cord blood (hUCB) by functional secretome analysis[J]. Mol Cell Proteomics, 2015, 14(10):2630-2643.
|